news
Lilly introduces cheaper generic insulin in the US
The generic version will cost 50 percent less that the current Humalog list price...
List view / Grid view
Formulation
article
Online drying process control of pharmaceutical intermediates using near-infrared spectroscopy in a bypass system
Strong regimentation and economic interests demand the development and implementation of new techniques for process control and analysis in the pharmaceutical industry. The extensive analysis of all deployed materials, intermediates and products leads to a higher degree of process stability and can contribute to a faster compensation for deviations, especially…
article
European Pharmaceutical Review Issue 1 2019
In this issue we look at the challenges of shipping temperature-controlled products, the potential use of blockchain for pharma, and using MALDI-TOF for identification of peptides in suspected illegal medicinal products. The edition also includes articles on aseptic containment, legal advice on licensing negotiations and an In-Depth Focus article from…
news
Policy to improve access and foster price competition for generics
A policy has been implemented to aid companies in the formulation, production and manufacture of generic drugs, especially when the originals are expensive...
news
Phase III clinical trial for treatment of dry eye syndrome
A Phase III trial looks to treat dry eye syndrome using a sterile, preservative-free eye drop formulation that has thymosin beta 4 as its active ingredient...
news
NICE and Canadian Agency collaborate to offer parallel scientific advice
NICE in the UK and its counterpart - the Canadian Agency for Drugs and Technology in Health have collaborated to offer parallel scientific advice...
news
Computational method could reduce the risk of drug formulations
A team of researchers have developed a computational method using an algorithm to develop formulations for drugs so they function properly...
news
Growing role of personalised and precision medicine in cancer treatments
The role of personalised and precision medicine may be ideal for the treatment of cancer, but questions about consequences and society issues still remain...
news
Making liposomal formulations for the delivery of RNA vaccines
A Dolomite Microfluidics’ set-up for high throughput single cell encapsulation is helping researchers at the Department of Medicine at Imperial College, London, to develop novel liposomal formulations for RNA vaccines targeting diseases such as HIV, influenza, rabies and chlamydia...
news
Freeze-dried TB vaccine candidate enters Phase 1 human clinical trial
A vaccine that does not require a cold chain could be much more easily distributed to communities in need…
news
Lithium treatment and GKS3 suppression could lead to kidney failure
Researchers have warned that certain psychiatric medications and treatments for bipolar disease could lead to the development of kidney failure...
whitepaper
Whitepaper: Solubility: Importance, measurements and applications
The solubility of a compound in organic solvents or water is equally important for screen design and later for process development.
article
Learning the unwritten rules and dynamics of power
As part of EPR’s Women in Pharma series, Nawal Ouzren, CEO of Sensorion, talks to Science Editor Dr Zara Kassam about the diversity in drug development, creating a new growth mindset and elevating conversations beyond obvious beliefs...
news
Computer programme that could bypass patents to produce synthetic drugs
Software that can bypass current intellectual property and design medication with the same function as top drugs could help pharma companies...
article
The obstacle to developing an optimum placebo formulation for pharmaceutical freeze drying
Scale-up of pharmaceutical freeze-drying processes is cost and time consuming due to Quality by Design (QbD) requirements and novel compound costs or availability. The application of placebo formulations offers a promising way to improve drug development activities and save resources. Furthermore, placebos are used as a reference in clinical trials.…
